Granules India Limited Receives ANDA approval for Glycopyrrolate Oral Solution
Granules India announced that the U.S. Food and Drug Administration has approved its Abbreviated New Drug Application for Glycopyrrolate Oral Solution 1mg/5mL filed by Granules Pharmaceuticals, Inc. , a wholly owned foreign subsidiary of the Company.